chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning her 5 year old grandson who in approximately August 1999 at 13 months of age, was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. In the end of May 2004, the patient developed a mild breakthrough case of varicella. Unspecified medical attention was sought. It was noted that therapy with varicella virus vaccine live was discontinued. Subsequently, the patient recovered. Additional information has been requested.
Information has been received from a nurse practitioner referring to an unspecified number of patient of unknown ages and gender. On an unknown dates the patients were vaccinated with GARDASIL (strength, lot#, dosage, frequency and route unspecified) and still ended up getting the HPV infection. The outcome of the event was unknown. Additional information is not expected because the reporter did not want to be contacted.
pt recvd vax;exp numbness in lt arm;flu like sx;itching,redness at site;tx w/Pred 14sep94 redness,chest tightness, to ER, breathing diff;tx w/ meds;16sep febrile synd;sinusitis;mult drug sensitivity
Low grade fever of 100.4; Severe body aches; Dizziness; Rapid heart rate; Rapid breathing rate; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 02May2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included isotretinoin (CLARAVIS) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. On 03May2021 at 16:00, the patient experienced low grade fever of 100.4 (units unspecified), severe body aches, dizziness, rapid heart rate, rapid breathing rate, soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever of 100.4 (units unspecified), severe body aches, dizziness, rapid heart rate, rapid breathing rate, soreness at injection site were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
ringing sound in her left ear and it is still with her; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing sound in her left ear and it is still with her) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 008B2112A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced TINNITUS (ringing sound in her left ear and it is still with her). At the time of the report, TINNITUS (ringing sound in her left ear and it is still with her) outcome was unknown.            Concomitant medication includes Birth control pills. Patient did not take any medication to treat these symptom.
arthritis; fell; This is a spontaneous report from a program. A contactable female consumer reported for herself that  A female patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EL9269) via unspecified route, in left arm on 24Feb2021 at 10:30 as 2 nd dose, single dose for covid-19 immunization. The patient medical history included high blood pressure from an unspecified date in 2000 and was ongoing; anxiety, degenerative bone disease and depression from an unspecified date in 2014 and was ongoing; asthma, COPD (Chronic obstructive pulmonary disease) from an unspecified date in 1998 and was ongoing. The concomitant drugs were not reported. The past drug included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, (Batch/Lot Number: EL3247), via unspecified rout, in left arm on 03Feb2021 at 09:30 for covid-19 immunization and also experienced Swollen gland, Slight headache on 03Feb2021 at 04:30. Prior to vaccination the patient had not taken any vaccine. The patient had arthritis and fell on 14Feb because of which she wanted to take medication in her back which the doctor had not given. The patient wanted to know if it is okay to take 800 mg of Tylenol since she received second dose of covid-19 today. The outcome of the events was unknown.  Follow-up (04May2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported in response to Non-HCP follow up letter sent which included: added the medical history high blood pressure, anxiety, degenerative bone disease and depression, asthma, COPD (Chronic obstructive pulmonary disease). Added the suspect drug details.   Follow-up attempts are completed. No further information is expected
Developed fever, body aches, chills 12/24 at ~6pm. Loss of taste and smell on ~12/26 that lasted ~5 days. Significant fatigue x ~7 days with return to work on day 10. Husband was already confirmed covid positive via rapid  test 12/22 with mild cold symptoms. I was confirmed positive via PCR 12/27. Initial rapid test 12/24 following symptom onset was negative, flu and covid PCR completed at urgent care were both negative on 12/25. Did follow up test due to loss of taste and smell for return to work through employee test site that was positive.
This spontaneous report as received from a medical assistant refers to an infant female patient of unknown age. On an unknown date between 13-MAY-2013 and 14-JUN-2013 the patient was vaccinated with RECOMBIVAX HB (2.5/0.5 units not provided), (0.5 ml intramuscularly, dose number unknowm) (lot # H020604 exp. date 10-FEB-2015). RECOMBIVAX HB that had a temperature excursion. No adverse effects were reported. This case is related with the following cases on same reporter link: 1307USA007921; 1309USA012210; 1309USA012211; 1309USA012212; 1309USA012213; 1309USA012215; 1309USA012216; 1309USA012217; 1309USA012218; 1309USA012219; 1309USA012220; 1309USA012221; 1309USA012222; 1309USA012223; 1309USA012224; 1309USA012225; 1309USA012226; 1309USA012227; 1309USA012228; 1309USA012229; 1309USA012230; 1309USA012231; 1309USA012232. Additional information is not expected.
sore swollen upper left arm,  body wide stiffness & aches, increased coughing , body wide chills, low grade temperature (96.1), headache, exhaustion, feeling chest heaviness, SaO2 85-88% on room air, no appetite, change in vision. I had to start using my oxygen (1L) again from night of 11/22/21  until mid morning of 11/24/2021. I have previously been off oxygen per nasal cannula during the day since 10/11/2021 and using oxygen at night until 11/14/21.
Recipient scheduled for dose #2.  Informed vaccinator that after receiving dose #1, experienced about 2 days later sx of hives on back, rash down both arms, and injection site became swollen.  Sx lasting for about 1 day only.  Denied experiencing any SOB, difficulty breathing, or any other sx.  Said did not seek medical attention.
Mother said that evening around 7:30 the child's nose became red and swollen and he had red splotches all over his body. Later that night the splotches turned to hives. By morning he had blister like areas with the hives. Mom called and reported to the nurse at 9:00 AM 4/17/18, I spoke to her again at 4:00 and the child still had the hives with the blisters. Called mom just now and she says he is better still has the hives and blisters. Mom works in a doctor's office, she had one of the nurse practitioners look at him as a friend but was not as a patient. The nurse practitioner recommend that she call us. This child's brother had a similar reaction but only splotches . The mom gave them both liquid BENADRYL.
Dry eye, ocular rosacea, facial rosacea, mybomian gland disfunction,  aqueous deficiency, extreme facial pain, increased thyroid problems (dosage of thyroid medication had to be increased.
Fever, chills, joint pain, fatigue. Receded 48 hours after vaccine.
Fever by the next morning\ fever of 101 F; Felt fatigue; General weakness; Felt bad for 48 hours; Achiness; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (General weakness), FEELING ABNORMAL (Felt bad for 48 hours), MYALGIA (Achiness), PYREXIA (Fever by the next morning\ fever of 101 F) and FATIGUE (Felt fatigue) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pain, Joint pain, Meningitis in 2014, Memory disturbance (Neurological memory issues) and Traumatic brain injury. Concurrent medical conditions included Bone spur (Bone spurs in her back, neck and joint pain at baseline.) and ADHD. Concomitant products included OMEPRAZOLE, LISDEXAMFETAMINE MESILATE (VYVANSE), BUPROPION, MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS, TRAMADOL and PARACETAMOL (TYLENOL) for an unknown indication.    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Dec-2020, the patient experienced ASTHENIA (General weakness), FEELING ABNORMAL (Felt bad for 48 hours), MYALGIA (Achiness) and FATIGUE (Felt fatigue). On 27-Dec-2020, the patient experienced PYREXIA (Fever by the next morning\ fever of 101 F). At the time of the report, ASTHENIA (General weakness), MYALGIA (Achiness), PYREXIA (Fever by the next morning\ fever of 101 F) and FATIGUE (Felt fatigue) outcome was unknown and FEELING ABNORMAL (Felt bad for 48 hours) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101F.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-326897 (Patient Link).; Sender's Comments: This case concerns a 42 year old female with a history of chronic pain, neck and joint pain, traumatic brain injury, meningitis 2014 and memory problems since then who experienced the non-serious unlisted events of Asthenia, Feeling abnormal and the non-serious listed event of Pyrexia, Myalgia and Fatigue. The events began at an unreported time after the first dose of Moderna COVID-19 vaccine. Re-challenge was positive as the patient reported the same events recurred with the second dose. The history of joint pain, back and neck pain, traumatic brain injury and general pain remain confounders as all can cause similar symptoms as the events reported. Benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.
hot (injection site area); injection side swollen; red (injection site area); itching on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot (injection site area)), VACCINATION SITE PRURITUS (itching on the injection site), VACCINATION SITE SWELLING (injection side swollen) and VACCINATION SITE ERYTHEMA (red (injection site area)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Flu vaccination ("Not an allergic person but previously had some reaction (unspecified) for her flu vaccine too."). Concomitant products included FLUOXETINE, MELOXICAM, VITAMIN B [VITAMIN B NOS] and VITAMIN D NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itching on the injection site). On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot (injection site area)), VACCINATION SITE SWELLING (injection side swollen) and VACCINATION SITE ERYTHEMA (red (injection site area)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and AMIKACIN SULFATE (AMICA) at an unspecified dose and frequency. On 08-Mar-2021, VACCINATION SITE WARMTH (hot (injection site area)), VACCINATION SITE PRURITUS (itching on the injection site), VACCINATION SITE SWELLING (injection side swollen) and VACCINATION SITE ERYTHEMA (red (injection site area)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment also included ice.
Heart Palpatations Chest Tightness Coughing Chills Body Aches Hot Flashes Shortness of Breath Congestion Muscle/Joint Pain
This spontaneous report was received from a other health professional (medical assistant) refers to a patient of unknown demographics. Patient's pertinent medical history and drug reactions were not reported. On 08-OCT-2014 the patient was inadvertently vaccinated with M-M-R II dose 1, intramuscular. It was reported as a result of this the patient was administered a second dose of M-M-R II subcutaneously at the same visit. No adverse effects were reported. No product quality complaint (PQC) was reported. Causality assessment was reported as not related to therapy with M-M-R II. Additional information has been requested.
GBS in reported in pt who recvd flu vax; pt had flu shot on 15NOV91 & on 30NOV91 devel weakness & paresthesias in lower extremities which progressed until 2DEC91; pt hospitalized due to inability to walk;
have been since then like having flu symptoms; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (have been since then like having flu symptoms) and FATIGUE (feeling tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (have been since then like having flu symptoms) and FATIGUE (feeling tired). At the time of the report, INFLUENZA LIKE ILLNESS (have been since then like having flu symptoms) and FATIGUE (feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications and treatment information was not provided.
1 st and 2nd dose were Moderna,  Pfizer was given as a 3rd dose
Patient received her first dose at 12:30pm and by the next morning, the patient had lymph nodes swollen under her left arm pretty significantly.  She also has swelling (a lump) at injection site.  She was very concerned about getting her 2nd dose and advised to contact MD.  She was applying ice packs and taking ibuprofen.
HYPOTENSION 10/29/2022, 12/24/2022,  1/6/2022, 12/6/2022, 11/18/2022, 2/9/2023, 1/16/2023,  2/18/2023 -  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Received 4 month immunization-Pediarix, Hib and PCV7 on 08/21/2006.  Developed rash on legs the next day when spread to arms, abdomen and back.  No breathing difficulty, no swelling of lips or tongue.
Body aches, chills, low grade fever, hallucinations on 4/21/21
Headache, CoughWheeze, chills Narrative:  Per nursing report:  "2nd dose of Moderna vaccine about 3pm when came in for work yesterday. This morning c/o non-productive  cough ,headache and feeling cold."
pt given 1st (L) arm Gardasil  then developed shingles (L) shoulder (L) upper ant chest and trunk approx 4 hours after Gardasil injection.
My husband got the vaccine and within 2 weeks he had lost 18 pounds, All of the weight was muscle and no fat.; His arms and legs lost almost all muscle tone; He was also completely exhausted; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (My husband got the vaccine and within 2 weeks he had lost 18 pounds, All of the weight was muscle and no fat.), HYPOTONIA (His arms and legs lost almost all muscle tone) and FATIGUE (He was also completely exhausted) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (My husband got the vaccine and within 2 weeks he had lost 18 pounds, All of the weight was muscle and no fat.), HYPOTONIA (His arms and legs lost almost all muscle tone) and FATIGUE (He was also completely exhausted). At the time of the report, WEIGHT DECREASED (My husband got the vaccine and within 2 weeks he had lost 18 pounds, All of the weight was muscle and no fat.) and HYPOTONIA (His arms and legs lost almost all muscle tone) outcome was unknown and FATIGUE (He was also completely exhausted) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment medication was provided.  Reporter said that her husband lost 18 pounds within 2 weeks of getting the vaccine.  Reporter said that her husband was tested for every kind of cancer and disease and everything came back negative.   Most recent FOLLOW-UP information incorporated above includes: On 27-Aug-2021: Non-Significant Follow-up On 14-Sep-2021: Follow-up received with NNI
First Day, 8.31.21 , Reddened face, watery eyes, blurry vision,  fatigue dizziness, soft stools, TeNonemperature: 100.4 F, sore throat, headache, Second Day, 9.1 .21 : Same as before, temperature 100.9 F, call the pharmacist tole me to take Tylenol,, at midnight, stronger headache,  Temperature: 102.8 F, I knew since last January , Tylenol give me adverse reactions but took  it anyway, I got the reactions and no effect the temperature went higher. Third Day:, 9.2.21, Took herbal teas, temperature went down to 100.1 F, headache, applied ice on forehead and head, A/C at 60 F, drank lot of water, ate well Fourth Day, 9.3.21 (today) took more herbal teas, Temperature 98.4 F at 5pm., dizziness, watery eyes and so blurry vision, light headache, ate well.
This sponaneous rerpot as received from a pharmacist refers to a patient of unknown age and gender. On 24-SEP-2014 the patient was vaccianted with RECOMBIVAX HB dose 1, 1 ml, intramuscular and was administered second dose on 24-MAR-2014. No adverse effects were reported. Additonal information is not expected.
Immediate burning sensation for 24 hr. Then red blotch 5 inches by 1 1/2 inches with itching continuously. Headache and low grade fever. Itching and sensitivity continues. Redness beginning to fade today - 7 days post vaccination.
Employee began having severe pain and slight swelling in the left armpit around 9 pm of the same evening of the day on which she  received her flu shot in the left deltoid at 11am. The injection site is also tender but there is no redness or swelling apparent at the site. The employee has tried using ibuprofen for relief at home without success. After reporting to work today, she c/o being unable to help lift any patients or objects of any substantial weight. She is in constant armpit pain at a level of 6-7/10 coupled with weakness of the entire left upper extremity. She has been sent to Employee Health Services for further evaluation in the Emergency Department.
Marked swelling around infection site RT thigh but not erythematous. Child is NAD, not irritable, not in pain. Warm compresses TID, Motrin 1tsp po q 6hrs per prn.
Psoriasis Developed 2 weeks after 2nd vaccination. First appeared behind right ear then on legs and arms.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (003110). The reporter is the patient.  A 75 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 24May2021 09:30 (Lot number: EW0168) at the age of 75 years as dose 2, single for covid-19 immunisation. No patient's relevant medical history was reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE: 1, 3  May I got my first shot of vaccine, Time: 9AM, Anatomical site of injection: Upper left arm, Route of administration: Intramuscular, Lot no: ER8731), administration date: 03May2021, for covid 19 immunization. The following information was reported: PSORIASIS (non-serious) with onset 14Jun2021, outcome "unknown", described as "Psoriasis Developed 2 weeks after 2nd vaccination. First appeared behind right ear then on legs and arms.". Therapeutic measures were not taken as a result of psoriasis.   Additional information: Customer Verbatim: I am no 76 and on 3 May I got my first shot of vaccine and then 24May the second and then 3 weeks later I developed psoriasis which I have never had before you have a cure for that. On 20Nov2021 at 09:00 am Patient received dose 3 on upper left arm intramuscularly (FG3527).Vaccination facility type was Pharmacy or Drug store, and vaccine was not administered at military facility. There were No Prior vaccination, no concomitant drugs and no patients medical history.   No follow-up attempts are possible. No further information is expected.
DTap given 2/23/04 awoke 2/24/04 with reddened itchy upper right arm. 13 x 10 cm hive noted with definite redness and halo effect to it. Itchy. No nodes pulp. The pt's reaction turned out to be an allergic reaction. Pt visited an allergist who determined that it was a reaction to the DTaP vaccine.